9,482 Shares in National Health Investors, Inc. $NHI Acquired by Moody National Bank Trust Division

Moody National Bank Trust Division purchased a new stake in National Health Investors, Inc. (NYSE:NHI – Free Report) in the 2nd quarter, Holdings Channel.com reports. The institutional investor purchased 9,482 shares of the real estate investment trust’s stock, valued at approximately $723,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. International Assets Investment Management LLC bought a new position in National Health Investors during the 4th quarter worth $27,000. EverSource Wealth Advisors LLC lifted its holdings in shares of National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after buying an additional 288 shares in the last quarter. Garton & Associates Financial Advisors LLC bought a new stake in shares of National Health Investors in the fourth quarter valued at about $33,000. Key Capital Management INC bought a new stake in shares of National Health Investors in the fourth quarter valued at about $47,000. Finally, Advisory Services Network LLC acquired a new position in shares of National Health Investors in the third quarter valued at about $65,000. 62.51% of the stock is owned by institutional investors and hedge funds.

Get National Health Investors alerts:

National Health Investors Stock Up 0.8%

NHI stock opened at $75.13 on Thursday. The company has a market cap of $3.64 billion, a PE ratio of 24.24, a price-to-earnings-growth ratio of 3.35 and a beta of 0.51. The business has a 50-day simple moving average of $75.09 and a 200 day simple moving average of $79.67. National Health Investors, Inc. has a 52 week low of $67.94 and a 52 week high of $91.38. The company has a quick ratio of 8.20, a current ratio of 8.20 and a debt-to-equity ratio of 0.83.

Insider Activity

In other news, CEO D. Eric Mendelsohn purchased 1,500 shares of the business’s stock in a transaction dated Friday, June 5th. The stock was bought at an average price of $68.84 per share, with a total value of $103,260.00. Following the acquisition, the chief executive officer owned 133,316 shares in the company, valued at approximately $9,177,473.44. The trade was a 1.14% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Robert A. Mccabe, Jr. purchased 890 shares of National Health Investors stock in a transaction that occurred on Monday, June 15th. The shares were purchased at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the transaction, the director directly owned 44,159 shares in the company, valued at $3,163,992.35. This represents a 2.06% increase in their position. The SEC filing for this purchase provides additional information. 2.70% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

NHI has been the topic of a number of recent research reports. Wells Fargo & Company lowered their price target on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a research report on Monday, June 1st. Zacks Research downgraded shares of National Health Investors from a “hold” rating to a “strong sell” rating in a report on Thursday, June 25th. Cantor Fitzgerald restated an “overweight” rating and set a $94.00 target price on shares of National Health Investors in a research report on Wednesday, April 22nd. Truist Financial lowered their target price on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a report on Friday, June 12th. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on shares of National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a research report on Thursday, June 25th. Five investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, National Health Investors has an average rating of “Moderate Buy” and a consensus target price of $83.86.

Get Our Latest Research Report on National Health Investors

About National Health Investors

(Free Report)

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

Featured Articles

• Five stocks we like better than National Health Investors
• SpaceX: Love the Company, But the Stock Is a Harder Call
• Ulta’s Growth Is Real, But So Are the Risks
• BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
• Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth

Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI – Free Report).

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.